...
首页> 外文期刊>Bone marrow transplantation >Relapse of Graves' disease after successful allogeneic bone marrow transplantation.
【24h】

Relapse of Graves' disease after successful allogeneic bone marrow transplantation.

机译:同种异体骨髓移植成功后,格雷夫斯病复发。

获取原文
获取原文并翻译 | 示例
           

摘要

As shown in many reports, allogeneic BMT can help cure autoimmune diseases. Conversely, we present a 24-year-old woman with Graves' disease, which was diagnosed just before BMT for CML. The Graves' disease remitted immediately after BMT but relapsed 18 months later. Since the donor was free from thyroid diseases and the patient showed a rapid shift to complete donor chimerism after BMT, the autoimmune problem seemed neither to arise directly from the donor nor simply from the recipient's residual lymphocytes. On the contrary, it was most likely compounded by chronic GVHD as suggested by the accompanying GVHD symptoms and the absolute donor karyotype in bone marrow cells. A Graves' disease-susceptible HLA allele was also shared between recipient and donor, possibly enhancing the chances of this condition developing. Thus, allogeneic BMT may facilitate relapses in autoimmune diseases as well as alleviating them.
机译:如许多报告所示,同种异体BMT可帮助治愈自身免疫性疾病。相反,我们介绍了一位患有Graves病的24岁妇女,该病在BMT之前就被诊断为CML。 BMT后Graves病立即缓解,但18个月后复发。由于供者没有甲状腺疾病,并且患者在BMT后表现出迅速转变为完全供者嵌合的状态,因此自身免疫问题似乎既不是直接来自供者也不是仅仅来自受体的残留淋巴细胞。相反,如伴随的GVHD症状和骨髓细胞中的绝对供体核型所表明的,慢性GVHD很有可能加重病情。受者和供者之间也共享了Graves易感疾病的HLA等位基因,可能会增加这种疾病发生的机会。因此,同种异体BMT可以促进自身免疫性疾病的复发并缓解它们。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号